| Literature DB >> 31806625 |
Joon Ho Moon1, Yeong Gi Kim1, Kyuho Kim1, Sho Osonoi2, Shuang Wang3, Diane C Saunders4, Juehu Wang5, Katherine Yang5, Hyeongseok Kim1,6, Junguee Lee7, Ji-Seon Jeong8, Ronadip R Banerjee9, Seung K Kim10, Yingjie Wu3,11, Hiroki Mizukami2, Alvin C Powers4,12, Michael S German13,14, Hail Kim15,16.
Abstract
A sufficient β-cell mass is crucial for preventing diabetes, and perinatal β-cell proliferation is important in determining the adult β-cell mass. However, it is not yet known how perinatal β-cell proliferation is regulated. Here, we report that serotonin regulates β-cell proliferation through serotonin receptor 2B (HTR2B) in an autocrine/paracrine manner during the perinatal period. In β-cell-specific Tph1 knockout (Tph1 βKO) mice, perinatal β-cell proliferation was reduced along with the loss of serotonin production in β-cells. Adult Tph1 βKO mice exhibited glucose intolerance with decreased β-cell mass. Disruption of Htr2b in β-cells also resulted in decreased perinatal β-cell proliferation and glucose intolerance in adulthood. Growth hormone (GH) was found to induce serotonin production in β-cells through activation of STAT5 during the perinatal period. Thus, our results indicate that GH-GH receptor-STAT5-serotonin-HTR2B signaling plays a critical role in determining the β-cell mass by regulating perinatal β-cell proliferation, and defects in this pathway affect metabolic phenotypes in adults.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31806625 PMCID: PMC6971487 DOI: 10.2337/db19-0546
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461